Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2020-06-15
2021-12-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of VDPHL01 in Males and Females With AGA
NCT06527365
Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL)
NCT02316418
Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata
NCT05368103
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
NCT07146022
Hairstetics Hair Implant Device Safety and Efficacy
NCT02856308
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects
Female subjects providing DNA saliva sample
HairDx Sample Collection Kit
Saliva collection using FDA OTC cleared sample collection device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HairDx Sample Collection Kit
Saliva collection using FDA OTC cleared sample collection device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Overall good health
* Able to give informed consent
* Willing to collect saliva sample
Exclusion Criteria
* Inability to provide informed consent in English
* Inability to follow instructions for saliva sample collection
* Non US resident
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Applied Biology, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John McCoy, PhD
Role: PRINCIPAL_INVESTIGATOR
Applied Biology, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Applied Biology, Inc.
Irvine, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Redler S, Birch P, Drichel D, Hofmann P, Dobson K, Bohmer AC, Becker J, Giehl KA, Tazi-Ahnini R, Kruse R, Wolff H, Miesel A, Fischer T, Bohm M, Nuwayhid R, Garcia Bartels N, Lutz G, Becker T, Blume-Peytavi U, Nothen MM, Messenger AG, Betz RC. The oestrogen receptor 2 (ESR2) gene in female-pattern hair loss: replication of association with rs10137185 in German patients. Br J Dermatol. 2014 Apr;170(4):982-5. doi: 10.1111/bjd.12756. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FI-HairDX-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.